-
RNAC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Cartesian Therapeutics (RNAC)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 220.87 mm | 220.87 mm | 220.87 mm | 220.87 mm | 220.87 mm | 220.87 mm |
Cash burn (monthly) | (no burn) | (no burn) | 5.86 mm | 20.05 mm | (no burn) | 2.89 mm |
Cash used (since last report) | n/a | n/a | 16.50 mm | 56.49 mm | n/a | 8.15 mm |
Cash remaining | n/a | n/a | 204.37 mm | 164.38 mm | n/a | 212.72 mm |
Runway (months of cash) | n/a | n/a | 34.9 | 8.2 | n/a | 73.5 |
13F holders | Current |
---|---|
Total holders | 67 |
Opened positions | 26 |
Closed positions | 26 |
Increased positions | 0 |
Reduced positions | 37 |
13F shares | Current |
---|---|
Total value | 82.08 bn |
Total shares | 25.20 mm |
Total puts | 0.00 |
Total calls | 10.20 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Artal International S.C.A. | 10.21 mm | $12.76 mm |
Mangrove Partners Master Fund | 3.33 mm | $10.10 mm |
Murat Kalayoglu | 3.04 mm | $39.84 mm |
Timothy A Springer | 2.09 mm | $27.48 mm |
Biotechnology Value Fund L P | 1.72 mm | $0.00 |
Vivo Capital IX | 1.37 mm | $4.00 mm |
FMR | 510.78 k | $13.80 bn |
BLK BlackRock | 407.60 k | $11.01 bn |
Michael Singer | 383.80 k | $5.04 mm |
JPM JPMorgan Chase & Co. | 306.33 k | $8.27 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Dec 24 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 18.9996 | 5,181 | 98.44 k | 8,507,895 |
20 Dec 24 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 18.9435 | 21,800 | 412.97 k | 8,502,714 |
19 Dec 24 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 18.928 | 3,376 | 63.90 k | 8,480,914 |
19 Dec 24 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 18.3496 | 10,529 | 193.20 k | 8,477,538 |
19 Dec 24 | Timothy A Springer | Common Stock | Buy | Acquire P | No | No | 17.3858 | 11,303 | 196.51 k | 8,467,009 |
10 Dec 24 | Metin Kurtoglu | Common Stock | Sell | Dispose S | No | No | 24.3503 | 2,901 | 70.64 k | 51,033 |
10 Dec 24 | Metin Kurtoglu | Common Stock | Option exercise | Acquire M | No | No | 1.41 | 2,901 | 4.09 k | 53,934 |
10 Dec 24 | Metin Kurtoglu | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.41 | 2,901 | 4.09 k | 79,099 |
9 Dec 24 | Metin Kurtoglu | Common Stock | Sell | Dispose S | No | No | 25.8333 | 4,539 | 117.26 k | 51,033 |
9 Dec 24 | Metin Kurtoglu | Common Stock | Sell | Dispose S | No | No | 25.2629 | 6,224 | 157.24 k | 55,572 |